https://specialty.mims.com/topic/elinzanetant-a-promising-nonhormone-treatment-option-for-vms--sleep-problems
The selective neurokinin (NK)-1,3 receptor antagonist elinzanetant appears to be beneficial in the treatment of vasomotor symptoms (VMS) and associate...
Create an account or login to join the discussion